$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224044972 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$347.0K
YoY Change		215.45%
Cost Of Revenue		$585.0K
YoY Change		320.86%
Gross Profit		-$238.0K
YoY Change		720.69%
Gross Profit Margin		-68.59%
Selling, General & Admin		$2.664M
YoY Change		113.98%
% of Gross Profit
Research & Development		$4.523M
YoY Change		459.78%
% of Gross Profit
Depreciation & Amortization		$538.0K
YoY Change		181.68%
% of Gross Profit
Operating Expenses		$7.187M
YoY Change		250.07%
Operating Profit		-$8.394M
YoY Change		-28.58%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$718.0K
YoY Change		41.34%
Pretax Income		-$9.234M
YoY Change		-24.68%
Income Tax		$32.00K
% Of Pretax Income
Net Earnings		-$9.120M
YoY Change		-27.92%
Net Earnings / Revenue		-2628.24%
Basic Earnings Per Share		$1.93
Diluted Earnings Per Share		$1.93
COMMON SHARES
Basic Shares Outstanding	5.169M shares	46.93M shares
Diluted Shares Outstanding		4.715M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$204.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$161.0K
Other Receivables
Total Short-Term Assets		$2.519M
YoY Change		-71.3%
LONG-TERM ASSETS
Property, Plant & Equipment		$14.90M
YoY Change		891.42%
Goodwill		$1.211M
YoY Change		-67.3%
Intangibles		$8.528M
YoY Change		13.28%
Long-Term Investments
YoY Change
Other Assets		$344.0K
YoY Change		-51.96%
Total Long-Term Assets		$27.17M
YoY Change		-25.61%
TOTAL ASSETS
Total Short-Term Assets		$2.519M
Total Long-Term Assets		$27.17M
Total Assets		$29.69M
YoY Change		-34.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses		$2.690M
YoY Change		33.5%
Deferred Revenue		$131.0K
YoY Change		9.17%
Short-Term Debt		$4.905M
YoY Change		1040.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$36.05M
YoY Change		152.06%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities		$2.456M
YoY Change		4134.48%
Total Long-Term Liabilities		$17.57M
YoY Change		-5.56%
TOTAL LIABILITIES
Total Short-Term Liabilities		$36.05M
Total Long-Term Liabilities		$17.57M
Total Liabilities		$53.62M
YoY Change		62.95%
SHAREHOLDERS EQUITY
Retained Earnings		-$204.4M
YoY Change		43.72%
Common Stock		$5.000K
YoY Change		-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.266M
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity		-$23.90M
YoY Change
Total Liabilities & Shareholders Equity		$29.69M
YoY Change		-34.46%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$9.120M
YoY Change		-27.92%
Depreciation, Depletion And Amortization		$538.0K
YoY Change		181.68%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Operating Income Loss OperatingIncomeLoss	-46901000	usd
CY2024Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-122000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38416
	dei	Entity Registrant Name EntityRegistrantName	ORGENESIS INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0583166
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20271 Goldenrod Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
	dei	City Area Code CityAreaCode	(480)
	dei	Local Phone Number LocalPhoneNumber	659-6404
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	ORGS
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	642000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2017000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	34000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4076000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	38000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1475000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7375000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	351000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1211000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10476000	usd
CY2023Q4	us-gaap	Assets Assets	14552000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14583333	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4799323	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4770666	shares
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	65000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-176622000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-20983000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20983000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14552000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	734000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	585000	usd
CY2023Q4	ORGS	Advance Payments From Customer AdvancePaymentsFromCustomer		usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2023Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent		usd
CY2023Q4	ORGS	Contingent Consideration Non Current ContingentConsiderationNonCurrent		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q3	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5169248	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	837000	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	918000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14397000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1236000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	2519000	usd
CY2024Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	55000	usd
CY2024Q3	ORGS	Investments To Associates InvestmentsToAssociates	8000	usd
CY2023Q4	ORGS	Investments To Associates InvestmentsToAssociates	8000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14901000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8528000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2121000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	1211000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	344000	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	27168000	usd
CY2024Q3	us-gaap	Assets Assets	29687000	usd
CY2024Q3	ORGS	Advance Payments From Customer AdvancePaymentsFromCustomer	6720000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2690000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2218000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	784000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1853000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1079000	usd
CY2024Q3	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	2771000	usd
CY2023Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	2180000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	4905000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	650000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	46000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	277000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	216000	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1966000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2670000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	36049000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16407000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1839000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96000	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	2828000	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	5435000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	18967000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4000	usd
CY2024Q3	ORGS	Contingent Consideration Non Current ContingentConsiderationNonCurrent	4906000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2456000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	17566000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19128000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	53615000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	35535000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14583333	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3216363	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3187706	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	181991000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	156837000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-215000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28656	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28656	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-23896000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-32000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23928000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29687000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	347000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	139000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1615000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6093000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-238000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-29000	usd
	us-gaap	Gross Profit GrossProfit	-881000	usd
	us-gaap	Gross Profit GrossProfit	-5728000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4523000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	808000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8382000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7616000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	196000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	575000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	568000	usd
CY2024Q3	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	81000	usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	263000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2725000	usd
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24367000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2664000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10781000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32989000	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2024Q3	us-gaap	Inventory Net InventoryNet		usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2024Q3	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
CY2023Q3	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q3	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses		usd
CY2023Q3	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses		usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses		usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024Q3	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
CY2023Q3	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
	ORGS	Noncontrolling Interest Adjustments To Additional Paid In Capital NoncontrollingInterestAdjustmentsToAdditionalPaidInCapital		usd
	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q3	ORGS	Noncontrolling Interest Adjustments To Additional Paid In Capital NoncontrollingInterestAdjustmentsToAdditionalPaidInCapital		usd
	ORGS	Convertible Loan Induced Conversion Expenses ConvertibleLoanInducedConversionExpenses		usd
	ORGS	Capital Loss Net CapitalLossNet		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
	ORGS	Credit Loss Related To Obi CreditLossRelatedToObi		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
	ORGS	Increase Decrease In Related Parties Net IncreaseDecreaseInRelatedPartiesNet		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation		usd
	ORGS	Impact To Cash Resulting From Another Deconsolidation ImpactToCashResultingFromAnotherDeconsolidation		usd
	ORGS	Proceeds From Transaction With Redeemable Noncontrolling Interest That Do Not Acquire Control Of Subsidiary ProceedsFromTransactionWithRedeemableNoncontrollingInterestThatDoNotAcquireControlOfSubsidiary		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	ORGS	Receipt From Purchaser ReceiptFromPurchaser		usd
	ORGS	Exchange Of Convertible Loans For Equity ExchangeOfConvertibleLoansForEquity		usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment		usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring		usd
	ORGS	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations		usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	458000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	740000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	52000	usd
CY2024Q3	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	101000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-204411000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1245000	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	692000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	692000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8394000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2235000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21574000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-114000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-718000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-545000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2385000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1918000	usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-553000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-552000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9234000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3331000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28584000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57681000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	394000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-9266000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3725000	usd
	us-gaap	Profit Loss ProfitLoss	-28637000	usd
	us-gaap	Profit Loss ProfitLoss	-58295000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-146000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-848000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9557000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-9120000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3725000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27789000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48738000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.93
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4715229	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4715229	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3002259	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3002259	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3938419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3938419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2868078	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2868078	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-9266000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3725000	usd
	us-gaap	Profit Loss ProfitLoss	-28637000	usd
	us-gaap	Profit Loss ProfitLoss	-58295000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	517000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-9000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	280000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	43000	usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera	-384000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	9783000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	3716000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	28917000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	57954000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	146000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	848000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	9557000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9637000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3716000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28069000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48397000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20983000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	304000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1506000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20311000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	745000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	141000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2496000	usd
	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	408000	usd
	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants	48000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28917000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23928000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	387000	usd
	ORGS	Stock Issued During Period Value Issuance Of Shares And Warrants Net Of Issuance Costs StockIssuedDuringPeriodValueIssuanceOfSharesAndWarrantsNetOfIssuanceCosts	4341000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	449000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	287000	usd
	ORGS	Adjustments To Additional Paid In Capital Deconsolidation AdjustmentsToAdditionalPaidInCapitalDeconsolidation	8430000	usd
	ORGS	Adjustments To Additional Paid In Capital Redemption Value Of Redeemable Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalRedemptionValueOfRedeemableNoncontrollingInterest	-9406000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-48931000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15372000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15792000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	89000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	816000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	714000	usd
CY2024Q3	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants	28000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9783000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23928000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12732000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12732000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	76000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	76000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3716000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15372000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15372000	usd
	us-gaap	Profit Loss ProfitLoss	-28637000	usd
	us-gaap	Profit Loss ProfitLoss	-58295000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2555000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	387000	usd
	ORGS	Convertible Loan Induced Conversion Expenses ConvertibleLoanInducedConversionExpenses	4304000	usd
	ORGS	Capital Loss Net CapitalLossNet	-134000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-552000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1625000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1366000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	ORGS	Credit Loss Related To Obi CreditLossRelatedToObi	2049000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	692000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	1672000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	106000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	-41000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	82000	usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	263000	usd
	ORGS	Interest Expense Accrued On Loans And Convertible Loans InterestExpenseAccruedOnLoansAndConvertibleLoans	-1366000	usd
	ORGS	Interest Expense Accrued On Loans And Convertible Loans InterestExpenseAccruedOnLoansAndConvertibleLoans	-880000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-30079000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1341000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1598000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	389000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10000	usd
	ORGS	Increase Decrease In Related Parties Net IncreaseDecreaseInRelatedPartiesNet	-2000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1951000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3925000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-846000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	266000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	168000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	135000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-9000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14978000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14335000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	263000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2096000	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	543000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	139000	usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation	5000	usd
	ORGS	Impact To Cash Resulting From Another Deconsolidation ImpactToCashResultingFromAnotherDeconsolidation	973000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	-202000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	33000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	73000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3645000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2556000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4341000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	75000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5660000	usd
	ORGS	Proceeds From Transaction With Redeemable Noncontrolling Interest That Do Not Acquire Control Of Subsidiary ProceedsFromTransactionWithRedeemableNoncontrollingInterestThatDoNotAcquireControlOfSubsidiary	5000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	251000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	33000	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	4670000	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	425000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	790000	usd
	ORGS	Receipt From Purchaser ReceiptFromPurchaser	6720000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14560000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12393000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-345000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5587000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-12000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1479000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1122000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	789000	usd
	ORGS	Exchange Of Convertible Loans For Equity ExchangeOfConvertibleLoansForEquity	16007000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	405000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	752000	usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	14000	usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	287000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
	us-gaap	Interest Paid Net InterestPaidNet	785000	usd
CY2024Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14583333	shares
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-204411000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14978000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zkOp1Bh0tJAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zXvgogRfYV1e">Use of Estimates in the Preparation of Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies. The Company bases its estimates on historical experience and on various other assumptions that it believes are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity, the amount of revenues and expenses, determination of loss on deconsolidation, valuation of investments, purchase price allocations, goodwill impairment, and assessment of credit losses and purchase price allocation including contingent consideration. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	734000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	1103000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-369000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	7922000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-10966000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	692000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-114000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1625000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2385000	usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28584000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	5616000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-5251000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	7331000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-32953000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1366000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1918000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-552000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57681000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	347000	usd
CY2024Q3	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	437000	usd
CY2024Q3	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-90000	usd
CY2024Q3	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	4337000	usd
CY2024Q3	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-2737000	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	692000	usd
CY2024Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-122000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	538000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-718000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9234000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
CY2023Q3	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	134000	usd
CY2023Q3	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-24000	usd
CY2023Q3	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	779000	usd
CY2023Q3	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-1241000	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-545000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-553000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3331000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	4905000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	650000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	50000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	50000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
CY2024Q1	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on March 7, 2024, one third on June 5, 2024, and one third on September 3, 2024.
CY2024Q1	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-03-06
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	50000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on April 18, 2024, one third on July 18, 2024, and one third on October 18, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-04-17
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	50000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on April 16, 2024, one third on July 16, 2024, and one third on October 16, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-04-22
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	47500	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on May 21, 2024, one third on August 21, 2024, and one third on November 21, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-05-21
CY2024Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	20000	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
CY2024Q3	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on July 14, 2024, one third on October 14, 2024, and one third on January 14, 2024.
CY2024Q3	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-07-13
CY2024Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	50000	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.3
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	350000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-9120000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3725000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27789000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48738000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4715229	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4715229	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3002259	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3002259	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3938419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3938419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2868078	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2868078	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.93
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	347000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	734000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
	ORGS	Accounts Receivable Reconsolidation AccountsReceivableReconsolidation	82000	usd
	ORGS	Accounts Receivable Reconsolidation AccountsReceivableReconsolidation	-5985000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	458000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	403000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-981000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-6090000	usd
	ORGS	Accounts Receivable Allowances For Doubtful Accounts AccountsReceivableAllowancesForDoubtfulAccounts	512000	usd
	ORGS	Accounts Receivable Allowances For Doubtful Accounts AccountsReceivableAllowancesForDoubtfulAccounts	-24388000	usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	2000	usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-52000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	71000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	160000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	156000	usd
	ORGS	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations	279000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	131000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	120000	usd
CY2024Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	8340000	usd
CY2024Q3	ORGS	Advance Payment From Customer AdvancePaymentFromCustomer	6720000	usd
CY2022Q1	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	In the Complaint, the plaintiffs are seeking that the Court issue a declaratory remedy whereby the defendants are required to pay royalties to the plaintiffs at the rate of 7% of the sales and 24% of any and all revenues in consideration for sublicenses related to any product, service or process that contain know-how and technology of Sheba and any and all know-how and technology either developed or supervised by Prof. Ferber in the field of cell therapy, including in the category of the point-of-care platform and any and all services and products in relation to the defendants’ CDMO activity
CY2022Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	10000
CY2023Q3	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	896000	usd
CY2023Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	40140
CY2023Q4	us-gaap	Shares Issued SharesIssued	1186960	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-044972-index-headers.html	Edgar Link	pending
0001493152-24-044972-index.html	Edgar Link	pending
0001493152-24-044972.txt	Edgar Link	pending
0001493152-24-044972-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgs-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
orgs-20240930_cal.xml	Edgar Link	unprocessable
orgs-20240930_def.xml	Edgar Link	unprocessable
orgs-20240930_lab.xml	Edgar Link	unprocessable
orgs-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2024 Q4 Form 10-Q Financial Statement

#000149315224044972 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2024 Q4 Form 10-Q Financial Statement

#000149315224044972 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs